| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,837 |
15,689 |
$2.33M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,484 |
6,437 |
$1.03M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,393 |
2,636 |
$363K |
| 80053 |
Comprehensive metabolic panel |
17,336 |
15,064 |
$308K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,751 |
1,650 |
$201K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,853 |
1,287 |
$131K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
262 |
238 |
$90K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,082 |
1,004 |
$86K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,580 |
17,736 |
$58K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
127 |
119 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
110 |
103 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,959 |
1,827 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,288 |
722 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
157 |
103 |
$19K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
307 |
277 |
$19K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
445 |
148 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
966 |
691 |
$16K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
150 |
128 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
76 |
59 |
$8K |
| 87088 |
|
385 |
342 |
$8K |
| 99215 |
Prolong outpt/office vis |
195 |
133 |
$7K |
| 90834 |
Psychotherapy, 45 minutes with patient |
162 |
70 |
$7K |
| 80061 |
Lipid panel |
653 |
625 |
$6K |
| 90837 |
Psychotherapy, 53 minutes with patient |
80 |
41 |
$6K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
217 |
93 |
$5K |
| 94060 |
|
257 |
160 |
$5K |
| 84484 |
|
408 |
333 |
$5K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
27 |
12 |
$4K |
| 94726 |
|
235 |
146 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,496 |
1,225 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,136 |
974 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
249 |
242 |
$3K |
| 83605 |
|
41 |
39 |
$2K |
| 94729 |
|
235 |
146 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
89 |
88 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,085 |
1,937 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
56 |
55 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,011 |
871 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
28 |
28 |
$2K |
| 86140 |
|
82 |
79 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,502 |
1,177 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
143 |
128 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28 |
28 |
$1K |
| 82728 |
|
120 |
111 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28 |
28 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,727 |
3,485 |
$1K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
312 |
268 |
$849.07 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
165 |
150 |
$847.04 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
28 |
$820.09 |
| 84439 |
|
65 |
64 |
$705.48 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,179 |
1,038 |
$543.55 |
| 83550 |
|
94 |
85 |
$470.42 |
| 83540 |
|
110 |
101 |
$445.76 |
| 87077 |
|
43 |
38 |
$442.23 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
854 |
790 |
$359.26 |
| 81003 |
|
976 |
901 |
$336.73 |
| 86803 |
|
14 |
14 |
$335.22 |
| 85652 |
|
84 |
82 |
$329.94 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
14 |
12 |
$318.02 |
| 71045 |
Radiologic examination, chest; single view |
526 |
477 |
$309.98 |
| 85379 |
|
14 |
13 |
$269.28 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
53 |
$210.24 |
| 82607 |
|
14 |
14 |
$209.30 |
| 83735 |
|
188 |
134 |
$146.49 |
| 86703 |
|
16 |
15 |
$142.60 |
| 83690 |
|
1,130 |
1,050 |
$122.97 |
| 87070 |
|
14 |
12 |
$112.55 |
| 84144 |
|
13 |
12 |
$104.10 |
| 87340 |
|
13 |
12 |
$94.16 |
| 84481 |
|
14 |
14 |
$89.64 |
| 86780 |
|
12 |
12 |
$80.60 |
| 81001 |
|
134 |
115 |
$75.39 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$43.59 |
| 85610 |
|
62 |
53 |
$38.07 |
| 87186 |
|
21 |
15 |
$25.68 |
| 84703 |
|
61 |
55 |
$8.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
68 |
54 |
$5.39 |
| 81025 |
|
46 |
41 |
$3.26 |
| 87634 |
|
13 |
13 |
$0.00 |
| 80306 |
|
12 |
12 |
$0.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
52 |
49 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
59 |
56 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19 |
15 |
$0.00 |
| 81002 |
|
72 |
29 |
$0.00 |
| 94664 |
|
14 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,110 |
730 |
$0.00 |
| J3490 |
Unclassified drugs |
1,923 |
992 |
$0.00 |
| G9637 |
Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) |
533 |
492 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
41 |
41 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
96 |
80 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
334 |
119 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
204 |
168 |
$0.00 |
| 85730 |
|
30 |
24 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
29 |
27 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
16 |
16 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
55 |
51 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
17 |
13 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12 |
12 |
$0.00 |